latest news releases from the newsroom
Patient Portal Technologies, Inc.
Patient Portal Technologies Announces Contract for HealthCast Services With the Iroquois Nursing Home
BALDWINSVILLE, N.Y., Sept. 24, 2008 (GLOBE NEWSWIRE) -- Patient Portal Technologies, Inc. (OTCBB:PPRG) announced today that it has signed an agreement to provide HealthCast(tm) customized patient network services to the Iroquois Nursing Home, a quality residential and short term rehabilitative care facility in Syracuse, NY. The agreement includes multiple health education channels and a customized information network to enhance communications between patients and facility.
Oriens Travel & Hotel Management Corp.
Oriens Travel and Hotel Management Corp. Featured On Stockbully.com
LAS VEGAS, Sept. 24, 2008 (GLOBE NEWSWIRE) -- Oriens Travel and Hotel Management Corp. (Pink Sheets:OTHM), a Las Vegas-based company that seeks out fragmented mid/lower end hotel properties in developing countries and re-organizes them under a unified name brand; Hotel PURE (www.HotelPURE.com), announced today that it is now being featured on www.stockbully.com.
Discovery Laboratories, Inc.
Discovery Labs Reports Technical Achievements Towards Gaining FDA Approval of Surfaxin
WARRINGTON, Pa., Sept. 24, 2008 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) announces that it has achieved technical success in addressing the key remaining requirements identified by the U.S. Food and Drug Administration (FDA) to gain marketing approval of Surfaxin(r) (lucinactant) for the prevention of Respiratory Distress Syndrome (RDS) in premature infants. Discovery Labs is completing the remaining activities and finalizing the information for its Complete Response to the May 2008 FDA Approvable Letter (Approvable Letter) and now expects to submit its Complete Response within the next four weeks. Discovery Labs continues to believe that the FDA may designate its Complete Response as a Class 1 resubmission, with a target review period of 60 days and potential approval of Surfaxin in 2008.